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oH~spmnl Centerl l~rnctl¢o l~ttom. ~ff~:t 
DJ  Whellan, 13, ~Not .o ,  JD  Abrams, A+!. Cuc¢lmafa, E, Lob Hos~al ot 
t ~  ~ P~sv~vama. ~ m LL~4 
/~lCAgmun~ Ca~t~!m transplant centa~ de!amine the treatment and lmnm. 
plant ~ status of ~ !  head ~ n t  (HTx) patmnts. We hy+ 
potheslzed ll~l i ~  transplant (~mler I~aClK~ pattet~t~ l~i~ Our local 
oK!an ~mme~ o~amzatmn (OPO) would m~ult in ddtorentmi ntm~ee l 
tmnsp~ntatm~, and cloal~ for status 1 Pa~ 
M~:  HT~ pa~ ~ as uNOS status I from 111/92 to 17.J31~35 
were anah/zed (n = 637). Pat~en~ ~re  compared by transplant center 
Ior age, ~,  e ~  el head faAum, blood type, brutal, moved ~om status 1 
(TM!), use OI mecham(~ ~ (MS), totalwanmg ks! brrm (TWT), and lolal 
status t l.ne (]'ST t) patron!. We pedomted logzspc and mutt]pie regre~smn 
Io+ ~ el trans~am cent~ on II~ numl0er el tranmplants 
and dealhs afte~ 90 days of TStl. 
Resu~.- A totaJ of 265, 96, !00, and 176 pahenls were hsted at each 
transptanl c"e~e~. IAean TSTI1 hm~ wa.~ 3~ : 36 day~, af'id n~_.a~ age 
wasSt ] 12Vt~,. ,~g~1~Ecant d~ffe~e~c'es we~eo4~i41mnad l~etween tTan~ant 
cenlers in etc41ogy of hesd tadure (p = 003). 1aNT (p .: 0.001). TSTt (p 1 
0001), and TM1 (p .  0.001) After a~luslmg for basel!tie dkfferences, the 
transplam cente~ mmamnd a s~;]n~am ~ of ~ansptam (p - O001) 
and death (p . 01(~1) a~ =tr 90 ~ TST1. 
Corzc/usc~" In our local OPO, praclzoe patlem~ between hansplant cen- 
ters Sagnd~canlly affected numbel of t ran~bons  and deall~ at 90 days 
TSTt It remains lobe astal~shed wl~ethe[ ~ represents ~ pallems 
nat~orta,y. 
• • - - •  Weeldly R isk  of  Death While Await ing 
Transplanlat ion: Relationship to Supped 
Requi red 
L.W. Stevenson+ RC Bo~,rge, D.C Nat!el. W Dec. 1: Krauskopf. 
J.B. Young.+ G M Mullen+ O.E. T~man R.J. Rodeheffer. J.K. Kirkhn. Car~ac 
Transplant Research Database (CTRD~: Brigham and Women's Hos~tal. 
Boston. MAL [ :mvers~fy ol Alabama. B+m~ngham. AL. USA 
Backgroe~ + The current system of pnon~ ~mplms a constant risk el death 
w~thm a g~en status, but nsks may change after listing. 
Methods: Weekly mot!aMy for 6 rr~s was determine for 978 pts wdbeut 
dev~-e at listing in the pre-Trans~ant Database and 284 pts from the Heart- 
mate (LVAD) registry. Non-LVAD pts were further d~KJed into Status I. pls 
hsled II but in hospital or on home IV =no!ropes (Status 1.5) and all oft)or II. 
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Resu/ts: Weekly nsk for Status II remained co~=-tant ~t 0.35 ± 0.14% for 
24 wks. LVAD pts had - 10% weekly mortality for 2 wks. declining to 0.75°0 
0.20% nsk after 5 wks. After 2 wks, weekly mortality was highest for Status 
L Status 1.5 pts had mortality comparable to LVAD pts but higher than Status 
II pts. 
Conclusion: By the time most LVAD pts are listed, weekly risk is similar to 
that for pts hospitalized outside ICU*s or on home inotmpes, but intermediate 
between nsk for other Status I and other Status II pts. Pnonty based on 
interval nsks may decrease waiting ILst deaths. 
• PoaHraneplantaf lon Survltml of  Pst lent l  With 
Mlopathl¢ Giant Cell Myocard l t i l  (GCM) Vemut  
uard lomyopMhy (CM) 
LT Coupe,, L J Olden, GJ Berry, H Tazelaar Mayo C#r~., Rocr~te~ 
MN, USA 
~'gk~'Ou~: Pub!isheq data §~t  suf~qval of paints t ra~nte~ for 
acute mvocardd=s i  wors~ than su~tval of ~ t f a ~  Io~ ca~ 
dmmyooathy. We ~ought o last the hypotho~m that patient= ~ GCM have 
a worse posHransldanl~t~ suP.wal than t;ml~nt~ ffafl~,nta~ fo~ CMr W~ 
~emlfmd 38 pat~ts lf0~ II~ Mtdl~n~T O,t~m Cell Myo~s 
who underwent rar~p!~flMt~t (TX) an() o~mpafe~ eunfl~l to !24 patents 
lransphtnted for CM at ,',~f instit~fJOr~, 
Re~p/fs: M~an age at ffansplantabon o! the GCM and CM groups were 
412 * 113 yearn and 486 r 145 y~a~ (Sft~eflt's T last, p = 0.004), 
and they were 53% and 19% female (¢11t square, p = 0.001). Kaplan.Mokl~ 
sulvwal was B8% and 71% at 5 ye~m fo~, ~ CM as¢l GCM gfou4~ (Fig 
1) U~vanata anah~s t~sing the Iog~ank ~ demonstrated wome survival 
in lhe GCM group (p = 0017~_) M.~vanata ana~yms ~mO a Cox model 
ndlusted for age ~nd gef~er suggeste~ that the survival was still worse m 
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Conclus+on Sutural =s worse m patmnts l ran~Inted for CICM Ihan 
m patents transplanted for CM at our ~nshtutmn; However, most deaths 
occuwnd m the first 30 clays postoperalwely and post-TX GCM sunnval Is 
cornpara.l~le to suP,(Nal in pubhslled TX reds!ties TX is an effective therapy 
for GCM 
~ L o n g  Effect iveness of Heart Term Urgent 
Transplantat ion (HTx)  Compared With Elect ive 
,'4Tx 
E GrendeL M. Fngeno, M Mangmvaccht. E '.rP, ah, F. Olwa, B. Andreuz~, 
G Comeno. G Masoncco, A+P Bares1. P+ Bart~en ~ , A. Pellegrini. "A. De 
Ga.spm'rrs" Camtm¢ Surgen/ and Card~,ogy Center, Heart Failure and 
C.ar#lac TrarTsplant Program. Nlguaro~ Ca' Gmnda h~l .  M#an. llaly: 
f Institute of Bcstatrstlcs. Utm/e~ of Milan. Italy 
Backgrouz~: WhereaS aftentmn has been focused on the influence of preop- 
eralzve status on early sunnval after HTx+ kltle m known about the possdde 
long term Tnpact el urgent versus electn~ HTx. 
Methods- In 500 patmnts (pts) w~ severe CHF referred 1o our Center 
for ellglbdity for HTx (median follow up 45 mor~ls), sunnval was compared 
among pts rnamtaWned on optimal medical therapy (n = 287)+ pls who under- 
went HTx (n = 151). and pts ftsted for HTx but not transplanted (n = 62). In 
the group of pts that underwent HTx. long term sunnval was also compared 
between 10is undergefng electwe HTx (status 2: n = 95) and urgent HTx 
(status 1: n=56] 
Resufts: The proporhOn~ of pts SUntiving at the end of follow up were 
-C% in ~ fitted pts. 88% tn transplanted pts and 44% in listed and not 
transplanted pts. Cumulatw, probabdity of surmval was 97% at I. 2 and 
3 years after etectpve I-IT ~, ~.~ 3~,o. 94% and 7~+ at 1. 2 and 3 years 
respectwely in status 1 rectp.,~nts; at tl~e end el follow up 95=;= vs 78% of 
pts transplanted are still ahv~ ~p - 0.001). Oiscnminant analysis revealed 
that pts who underwent urger,: HTx had higher capillary wedge pressure 
(26.3 ± 9.0 vs 24.3 ± 12.8 mm Hg), higher bilirubin (2,65 ± 3.38 v,~ 1.70 ± 
1.69 mg/dl) and lower sodium (126 ± 6 vs 130 ± 5 mEq~). No statistically 
significant differences were detected regarding mean isc'nemic t~me (135.0 
483 vs 132.8 ± 52.5 minutes) and mean donor age (33.5 ± 12.3 vs 29.8 
± 13.3 years) between the two groups, 
Comments: The long term suwivat of non-refractory CHF pts treated with 
optimal medical therapy is comparable with long term survival of refraCtOry 
CHF pts treated with HTx. In status 1 candidates long tetra sunnval appeared 
. .3.A AIISI'II.~C'I',~ Po~ler ,IACC Febntary 19~18 
to be lower than m statu~ 2 candidates, The reasons for this difference could 
net be explained by our data nnd further investigations am required, In order 
to maintain status 1 candidature lot pfs who othon~lso would need urgent 
HTx, optimal mrmaonmenl of pretrnnRph~nt lhmnpy Cmlld tncludn nloclive 
assist device implantation, 
~Four  Year With the Funotlonal and Exp,;rlenco 
Morphologlod Adaptation of gnderalzed Donor 
Hearta Following Cardiac Transplantation 
P,J, Mother, V, Joevnnandam, A,A, Bove, Temple Unlv~mlty School of 
Marl~clan, Philadelphia, Penn~ylvanh't, U~A 
We compared our experience with the lrnn~pl~ntntian of 71 tmder~i:,ed 
donor hearth over a lout year ponod to a cohort group of 71 normal si~'od 
donor hlt~rln, The donor to recipient weight ratios wore OB5 :t 0,08 for the 
undarslilod houris, nnd 0,gg ~ 0,08 for normal st~od hoods, Loll ventriculnr 
m~ss (LVM) wn~ obtained by echo~nrdlogr~phy, H~modvnnml~n and VO.~ 
m~x wore obtained ~t yearly intervals, 
10 Wneks elm Year (N = 71) Finn Y~rs 
Undmsi,~o~ Nom~l Llndmaitnd Nmm~l Unilm;~tn0 Normal 
LVM tR5 I 2,t ll~g I 3fi 100 I 3 ,~ 15f~ I '|a 1t~4 I :15 tt~l~ I ,31! 
vO~ ~ o~ygt~n CO!l~ttmphl]o nlnul;ls~ tnttt [ml/k~imml PVI~I ¢ pulmnnmy v,~scol~f =os*~. 
tl~n~o two011 llnl1~); L,VM ~ In 0r~ms, N = 4? t~t llnflert~l¢od ¢11 t0llr yn~lra ,loll N ~ 57 h,~ 
nOH'Si~t~l atJOlll V~l~ 
Tho increase In LVM in the undofflit, od heart~, and Ihon tllair st~bsoquont 
01nteatl over lime sugget~t tl~at fl~o loft ventricle adopts to the larger recipient 
circulation, The functional (~apacity of the two greup,% homodynamics, and 
~(=rvlval talon are not significantly dilfemnl, Therefore, dospilo donorvalion 
and a mismatched lend, transDlanted heads adopt npproprialoly to their 
now homodynamlc milieu, titus suggesting the cardiac donor pool can be 
e~pandod to incktdo undors~tnd hearts, 
~ Can AntI.HLA Antibodies Post Cardleo 
............................... 'lYaneplantatlon Predict Clinical Out¢ome? 
G, Bhat, T,J, Schroodor, K. B~lakrighnan. University o/CmctnnatL 
Cincinnati. OH, USA 
Etackgro(md; The penni reactive antibody (PRA) test is used for HLA anti- 
body screening in transplanlotion. The purpose 0t this study was tO determine 
anfi-HLA class I lug antibodies by ELISA-basod assay (PRA-STAT) post-car- 
d~ac transplant (PCT} and correlate with clinical outcome. 
Methods; Pro and PCT sere from 107 patienls tptsl undergoing primary 
cardiac transplantation wore retrospectively analyzed. All pts received an 
OKT3 lmmunosuppmsswe protocol followed by topic therapy; graft survival 
was 80,4% with a mean follow up of 45 months trance 16-79). Clinical 
outcomes were analyzed as episodes of ::3A grade acute roiecfion (AR} 
within 31, 60, ~lnd 90 days, time (days) to tirst episode of AR, graft loss within 
60 days and overall grail loss. 
Re.~utts: Pin with PCT PRA.STAT at day 10 :.10% vs . 10": h~d 39% 
Compared to 14.6% overall graft less (p = 0.041), and 166% Compared to 
2,6% graft loss within 60 days (p = 5 048), 41 pts oxponencing AR within 31 
days had a significantly higher PRA-STAT (10.2 :t 2,4% vs. 3.3 :t, 2,2%, p = 
0,038) compared to 48 pts with no AR. Pts with PRA-STAT at day 10 PeT 
-15% vs . .  15% had first AR at 22.~ ± 12.4 days compared to 48.9 ± 45  
days (p = 0.052). Similar PRA.STA "~" results were obsen/ed with day 20 and 
30 samples. Increasing PRA dunng the first month was associated with a 
significant increase in AR 
Conclusions: PRA-STAT results PeT correlated with early and late graft 
loss and incidence of acute rojo'~tion. 
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I1098-173 ] Ectoplc Beats set the Stage for Torsade de 
Polntes Arrhythmlas by an Important 
Contribution to Interventricular Dispersion 
B. GOreneck, C. Verduyn, M.A. Yes, H,J.J. Wellens. Cardiology, Maastricht, 
The Netherlands 
Usually, a short long short sequence (SLS) caused by ectopic beats (EB) 
precedes the onset of Tornado do Pointos arrhylhmios (TdP). Because the 
coupling interval of EBs often foils within the QT or action potential duration 
(APD), tllelr role in the dynamicn of (dispomion ol) repoladzation is difficult 
to assess, In 17 anesthetized dogs with complete chronic AV block, we 
meast.ed APD~o0 nnd APD~0 of the left nnd right ventricle (LV, RV) using 
ondoonrdtal monophonic actmn polontlnt cnthotora, Admlntstr~bon Qt das~ 
III agents almakalant (n = 9) or Ibutllido (n ,, 8) msultl~;I in npont~n~ou~ TdP.. 
Dispomion (~APD) was defined as LV APD.RV APD and was t~Iormln~l 
for the last normal bent prior to TdP (l~nt I), the bent followed by EB but not 
ro~ulting in TdP (11) find the bo~t directly preceding TdP (111), 
Regality: The class III drug~ incml~spd APD, th~ % in~m,~se of the APDt0o 
and APD~0 wan ¢ompftrabte in both v~nlricle~ (r =- 0,?~, ;; .: 0,00t), In / '  
dogs the TdP started sttddon i,e, not preceded by SLY,, Th~:~e ~ had a 
slgnilionntly longer AAPD at boat I, than the non ngddr~n graop (table), In the 
non st(ddon group, the soqtmnce of EBs incm~sed the LV APD bet n~l the 
RV APD loading to ~ similar AAPD ns the su~n onset liable), 
.~l¢ldden Onset In = 71 Non m!dden onset In ~, 10) 
LV ^ eDge fit0 ~ 33 395 ; 3~ 419 ~ 33 450 ~ 3,3' 
FIV ^ PD~ tSt~ ~ 26 330 ~ 36 332 t .!5 ~ • 43 
' P , O Q~ VS Ue~t I non sllddon onset 
Conchlsi~ns: When the magmtudo el ~\AIP~I is, not ta~ e~h lor poe 
El3 to tagger TdP, the sequence ot EBs can further increase AAPD and 
f )eroby sot fan stage lot TdP, 
~09~ Loll Vontrlculsr Hypertrophy Incremmli 
VulnereblUt V to Bmdycardla end !)-Sotalol 
Induced Early Afferdepoladntions 
S,J Rials, Y, Wu, T~ Liu, X. Xu, D,D Bharucha, RA Mannchak, PR. Kowey 
Lankenatl Hospital and t, Md~cal Research Center, t%,nne~ood. PA. USA 
Loft vonfoculat hypertrophy (LVH) is known to prolong action potentml du. 
ration (APD) and increase the nsk of ventncular armythmta, possibly by 
generating early afterdepolanzations (EAD}. It tree, then LVH preparations 
should be morn vulnerable to class III induced EAD. We e,,amined whether 
APD prolongation by LVH leads to EAD using transmembrane achon poten- 
hals recorded in artonally poffused wedges el ventocles tram ral~ts wSh 
LVH Recordings were made at multiple pacing cycle lengths (PCL), both pro 
and post poffusion with 1 j im d-sotaloL LVH preparations shOwed greater 
prolongation el APD at longer PCL m a reverse use dependent manner, both 
before and after d-sotalol (p . 0.05 vs control) 3 el 8 LVH preparations 
showed EAO pro solalol and 7 of 8 LVH preparations shov.~l EAD post 
sotalol. None of the control preparations showed EAD either belore or alter 
sotalol (p .  0.05 vs LVH). EAD in the LVH preparations were obsenm~l to 
tagger achon polontials ,n surreundmg tmsue and to cause premature bears 
on transmuter ECG We conclude that LVH increases vulnerability to brady- 
cardia and 1o d-spieler induced EAD. These EAD car~ reach threshold and 
propagate to surrounding tissue. These data demonstrate that drugs that 
increase action potential duration may promote venmcular prOarrhythmia in 
LVH by ineroasiv, g vulnerability to EAD. 
~098-1751 Effects of QulnaprUat Electrophyslologlo 
" Changes During Acute Myocardial Ischemla and 
Following Reperfuslon In Canines 
H Fu]ioaga. T. Wakatsuki. K, Sakabo. J. Ikata. T. Toyoshima. A Nishikado. 
T. Oki. S. fro. Tokushima Universi~ Tokushima. Japan 
Purpose." We examined the effects of angiotensin conveding enzyme inhibitor 
as qumaprilat on the etectrophysiologic hanges dunng acute myocardial 
ischemia and following repedusion. 
Methods: The left anterior descending (LAD) coronary artery was Iigated 
for ten minutes and then reopened for ten minutes in 33 canines. They were 
divided into two groups (the quinaprilat group; 14, the control group; 19). The 
qumapnlat group received quinaprilat by an infusion of 3 p g/kg/min from 10 
min before the ligation to the end of examination. The control group received 
normal saline. We compared changes in the ventricular effect:.ve refractory 
period (ERP) of LAD regic~ during myocardial ischemia and following raper- 
fusion, and incidence of ventricular fibrillation (Vf) between the two groups. 
ERP values during procedure were divided by those before coronary ligation, 
and expressed as percentages. 
Results." ERP of both groups were as follows: 
Occlusion time [min} 2 4 6 8 10 
Quinaprilat group 101 ~ B 103 :t: B 102 :t 9 105 ~- 11 106 ± 14 
Control group 97 t 7 96 ± 9" 92 ~ 9" 88 ± 9"'" 91 ± 11"" 
